Common Stock, Shares, Outstanding of Forte Biosciences, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Forte Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Forte Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 12,523,845, a 758% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Forte Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 12,523,845 +11,063,838 +758% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 12,282,024 -24,160,356 -66% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 6,581,667 -29,813,215 -82% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 6,393,323 +4,939,921 +340% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,460,007 -34,821,765 -96% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 36,442,380 +15,391,185 +73% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 36,394,882 +15,387,813 +73% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 1,453,402 -19,546,667 -93% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 36,281,772 +15,281,703 +73% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 21,051,195 +6,289,934 +43% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 21,007,069 +6,245,808 +42% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 21,000,069 +6,245,622 +42% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 21,000,069 +6,245,622 +42% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,761,261 +682,204 +4.8% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 14,761,261 +1,249,545 +9.2% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 14,754,447 +1,923,849 +15% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 14,754,447 +3,537,884 +32% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 14,079,057 +2,880,742 +26% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 13,511,716 -10,403,007 -44% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 12,830,598 +10,722,332 +509% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 11,216,563 -12,681,148 -53% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 11,198,315 -12,697,427 -53% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 23,914,723 +703,861 +3% 31 Mar 2020 10-Q 23 Apr 2020 2020 Q1
Q4 2019 2,108,266 -20,891,885 -91% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 23,897,711 +3,944,702 +20% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 23,895,742 +3,944,584 +20% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 23,210,862 +3,298,719 +17% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 23,000,151 +3,117,600 +16% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 19,953,009 +143,560 +0.72% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 19,951,158 +141,709 +0.72% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 19,912,143 +17,684,976 +794% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 19,882,551 +17,680,034 +803% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 19,809,449 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 19,809,449 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 2,227,167 31 Mar 2017 10-Q 23 May 2017 2017 Q1
Q4 2016 2,202,517 31 Dec 2016 10-K 09 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.